Private Equity

  • October 31, 2024

    Blank Rome Adds Commercial Real Estate Expert In DC

    The former president and general counsel of Edge Funds Management LLC has joined Blank Rome LLP as an of counsel in the real estate group.

  • October 30, 2024

    Brookfield Scoops UK Wind Farms Assets In $2.3B Deal

    Brookfield has agreed to buy a minority stake in four of Danish multinational energy company Orsted's operational U.K. offshore wind farms in a deal valued at £1.745 billion ($2.27 billion), Orsted announced Wednesday. 

  • October 30, 2024

    Kirkland Leads Berkshire Partners To $7.8B Fund Close

    Boston-based private equity shop Berkshire Partners, advised by Kirkland & Ellis LLP, announced on Wednesday that it clinched its largest fund ever after securing $7.8 billion in investor commitments.

  • October 30, 2024

    AI-Focused SPAC Joins Pipeline With $200M IPO Filing

    Archimedes Tech SPAC Partners II Co., a special purpose acquisition company targeting the artificial intelligence industry, filed plans on Wednesday for an estimated $200 million initial public offering, while another SPAC, energy-transition focused Tavia Acquisition Corp., downsized plans.

  • October 30, 2024

    KKR, ECP To Plug $50B Into Data Centers, Power Projects

    Private equity firms KKR & Co., advised by Simpson Thacher, and Energy Capital Partners have teamed up to inject $50 billion into building data centers and energy generation projects in a bet on meeting rising demand for infrastructure to support the artificial intelligence boom.

  • October 30, 2024

    Cleary-Led UK Investor To Buy Data Security Biz For £169M

    Bridgepoint said Wednesday that its subsidiary has agreed to buy data security firm Eckoh PLC for £169.3 million ($220 million), as the British private investor seeks a slice of the growing global digital safety sector.

  • October 30, 2024

    Kirkland-Led Francisco Paying $1.1B For AdvancedMD

    Kirkland & Ellis LLP is guiding Francisco Partners on an agreement disclosed Wednesday to buy medical payments company AdvancedMD from Global Payments for $1.125 billion.

  • October 30, 2024

    Akin Gump Bolsters PE Team With Ex-Greenberg Traurig Atty

    Akin Gump Strauss Hauer & Feld LLP announced the addition of a private equity transactions attorney joining the firm in New York on Wednesday, saying the former Greenberg Traurig LLP shareholder will support the firm's position in the private capital market.

  • October 29, 2024

    Argent Strikes Symbria ESOP Suit Settlement Deal

    A class of Symbria Inc. workers alleging mismanagement of their employee stock ownership plan told an Illinois federal court they had reached a settlement with ESOP trustee Argent Trust Co. to end their federal benefits lawsuit.

  • October 29, 2024

    Sham Getty Stock Offer Lands Investor 10-Month Prison Term

    A former Massachusetts corporate executive will serve 10 months in prison for launching a sham takeover bid for Seattle-based Getty Images Holdings to drive up its share price and make hundreds of thousands of dollars in profit, a Boston federal judge said Tuesday.

  • October 29, 2024

    Greenberg Traurig Adds Bradley Arant Banking Ace In Dallas

    Greenberg Traurig LLP has brought on a former Bradley Arant Boult Cummings LLP counsel to its Dallas office to meet client demand, bolstering the firm's expertise in guiding banks on financial regulatory compliance and enforcement matters with a former senior attorney for the Federal Deposit Insurance Corp., the firm announced Tuesday.

  • October 29, 2024

    Warren Pushes FTC Chair To Probe Oncology Acquisitions

    Massachusetts Sen. Elizabeth Warren on Tuesday urged the Federal Trade Commission to scrutinize McKesson Corp.'s proposed $2.49 billion acquisition of a controlling stake in Core Ventures, and Cardinal Health's proposed $1.12 billion purchase of a controlling stake in Integrated Oncology, saying the deals would further consolidate the "already highly consolidated" oncology market.

  • October 29, 2024

    Burns & Levinson Atty Duo Latest To Join Blank Rome

    Blank Rome has announced it added a pair of attorneys from Burns & Levinson to its office in Boston, a move that the firm said bolsters its litigation and corporate capabilities and serves as the latest example of lawyers moving between the two firms since Blank Rome opened the office in April with 25 Burns & Levinson corporate and finance attorneys.

  • October 29, 2024

    M&A Rebounded As Equity Issuance, IPOs Faltered In Q3

    The number of global M&A deal announcements increased for the second consecutive quarter in the third quarter, but global equity issuance and IPO activity slowed, according to a Tuesday report from S&P Global Market Intelligence.

  • October 29, 2024

    Front Office Sports Sued For Using Luxury Real Estate Photos

    Private equity-backed media outlet Front Office Sports is accused of unlawfully using luxury real estate photos online without permission, according to a lawsuit filed in New York federal court.

  • October 29, 2024

    Crescent Inks Oncology Merger With $200M In Private Funding

    Crescent Biopharma Inc. has agreed to take fellow cancer-focused biotech GlycoMimetics Inc. private in a deal that includes $200 million of investments from well over a dozen firms to help fund the combined company's operations through 2027, GlycoMimetics revealed Tuesday.

  • October 29, 2024

    PE-Owned Implant Maker Plagued By Lawsuits Hits Ch. 11

    Joint implant maker Exactech Inc. on Tuesday filed for Chapter 11 protection in Delaware bankruptcy court with an offer from its lenders to take over the company, as a wave of lawsuits tied to product recalls weighs on the private equity-owned firm.

  • October 29, 2024

    Blackstone Brings In $22B Total For Direct Lending Platform

    Private equity giant Blackstone, advised by Simpson Thacher & Bartlett LLP, on Tuesday revealed that it successfully closed its inaugural evergreen institutional U.S. direct lending fund after securing a total of $22 billion in capital commitments.

  • October 28, 2024

    Masimo Sues Founder Over Alleged 'Empty Voting' Scheme

    Masimo Corp. has sued its founder for allegedly conspiring with an investment firm and company stockholder to manipulate a shareholder vote in order to maintain his seat on the medical technology company's board of directors.

  • October 28, 2024

    Ex-Atty Charged With $9.2M Commodities Ponzi Scheme

    Federal prosecutors have charged a former New Orleans-based attorney with operating a Ponzi scheme, saying he promised dozens of individuals that he would invest their $9.2 million in low-risk commodities when he was really using the funds to gamble and to pay off personal expenses.

  • October 28, 2024

    Ex-Oracle Manager, Software Co. Face Trade Secrets Suit

    A new lawsuit by Oracle claims that a manager left the company for a competing venture-backed construction software tech outfit and "absconded with thousands of Oracle's trade secret[s]."

  • October 28, 2024

    Creditors Get Ponzi Finding In Wash. Bankruptcy Trial

    A Washington state bankruptcy judge has found that real estate investment firm iCap Enterprises Inc. had operated as a Ponzi scheme, opening up the door for creditors to bring lawsuits and deduct some part of the losses from their taxes, attorneys for the official committee of iCap's unsecured creditors said Monday.

  • October 28, 2024

    5 Firms Guide Nearly $10B Garda World Security Deal

    London-based private equity firm BC Partners is selling its majority equity interest in Garda World Security Corp. to a group led by the security service provider's CEO, in a transaction steered by at least five law firms that values GardaWorld at CA$13.5 billion ($9.7 billion).

  • October 28, 2024

    Attys Seek $48M Fees For Hooking $152M In Tuna Fixing Deals

    Lawyers for a class of consumers that sued three of the largest tuna producers accusing them of conspiring to fix tinned fish prices asked a California federal court to approve nearly $50 million in legal costs after a settlement this summer ended nearly nine years of multidistrict litigation.

  • October 28, 2024

    AbbVie Paying $1.4B For Alzheimer's-Focused Biotech

    AbbVie said Monday it will acquire Aliada Therapeutics, a biotechnology company working on therapies to treat central nervous system diseases including Alzheimer's disease, for $1.4 billion in cash. 

Expert Analysis

  • PE Firms Should Prepare For Increased False Claims Scrutiny

    Author Photo

    The impact private equity firms may have over medical decisions and care is increasingly attracting potential liability under the False Claims Act and attention from states and the federal government, so investors should follow best practices including conducting due diligence both before and after acquisitions, say attorneys at K&L Gates.

  • Series

    A Day In The In-House Life: Block CLO Talks Problem-Solving

    Author Photo

    Amid the busy summer months, Block Inc. Chief Legal Officer Chrysty Esperanza chronicles a typical Wednesday where she conquered everything from unexpected fintech regulatory issues and team building to Bay Area commutes and school drop-off.

  • How To Grow Marketing, Biz Dev Teams In A Tight Market

    Author Photo

    Faced with fierce competition and rising operating costs, firms are feeling the pressure to build a well-oiled marketing and business development team that supports strategic priorities, but they’ll need to be flexible and creative given a tight talent market, says Ben Curle at Ambition.

  • FTC Focus: Private Equity Investments In Healthcare

    Author Photo

    As the Federal Trade Commission is tightening its scrutiny of private equity investment in healthcare, the agency is finding novel grounds to challenge key focus areas, including rollup acquisitions, the flip-and-strip approach and minority investments in rival providers, say attorneys at Proskauer.

  • Jarkesy's Impact On SEC Enforcement Will Be Modest

    Author Photo

    Though the U.S. Supreme Court’s recent U.S. Securities and Exchange Commission v. Jarkesy decision found that fraud defendants have a constitutional right to a jury trial, the ruling will have muted impact on the agency’s enforcement because it’s already bringing most of its cases in federal court, say Jeremiah Williams and Alyssa Fixsen at Ropes & Gray.

  • Series

    Rock Climbing Makes Me A Better Lawyer

    Author Photo

    Rock climbing requires problem-solving, focus, risk management and resilience, skills that are also invaluable assets in my role as a finance lawyer, says Mei Zhang at Haynes and Boone.

  • How 5 States' Deal Notification Laws Are Guiding Healthcare

    Author Photo

    Healthcare transaction notification laws at various stages of implementation in California, Illinois, Indiana, Oregon and Washington are shaping sector mergers and acquisitions, with significant transparency, continuity of care and compliance implications as providers tackle complex regulatory requirements, says Melesa Freerks at DLA Piper.

  • Think Like A Lawyer: Dance The Legal Standard Two-Step

    Author Photo

    From rookie brief writers to Chief Justice John Roberts, lawyers should master the legal standard two-step — framing the governing standard at the outset, and clarifying why they meet that standard — which has benefits for both the drafter and reader, says Luke Andrews at Poole Huffman.

  • Behind The Delay Of Final HSR Premerger Filing Rules

    Author Photo

    Erin Toomey at Epiq discusses the wait for the final version of the revised Hart-Scott-Rodino premerger filing requirements that were first introduced in June 2023, the factors that might be behind the delay, and how to plan for the potential data-focused rule change

  • Opinion

    The FTC Needs To Challenge The Novo-Catalent Deal

    Author Photo

    Novo's acquisition of Catalent threatens to substantially lessen competition in the manufacturing and marketing of GLP-1 diabetes and obesity drugs, and the Federal Trade Commission should challenge it under a vertical theory of harm, as it aligns with last year's merger guidelines and the Fifth Circuit decision in Illumina, says attorney David Balto.

  • Series

    Being A Luthier Makes Me A Better Lawyer

    Author Photo

    When I’m not working as an appellate lawyer, I spend my spare time building guitars — a craft known as luthiery — which has helped to enhance the discipline, patience and resilience needed to write better briefs, says Rob Carty at Nichols Brar.

  • Lead Like 'Ted Lasso' By Embracing Cognitive Diversity

    Author Photo

    The Apple TV+ series “Ted Lasso” aptly illustrates how embracing cognitive diversity can be a winning strategy for teams, providing a useful lesson for law firms, which can benefit significantly from fresh, diverse perspectives and collaborative problem-solving, says Paul Manuele at PR Manuele Consulting.

  • Today's Trends In Private Credit And Unitranche Financing

    Excerpt from Practical Guidance
    Author Photo

    Proskauer’s Michelle Iodice analyzes recent patterns in private credit and unitranche financing transactions, including the rise of super-senior revolver loans as an alternative to traditional structure, and considers how they may shape the private credit and broadly syndicated loan markets through the remainder of 2024.

  • The Good, The Bad And The Ugly Of Healthcare's PE Boom

    Author Photo

    While an influx of capital may provide access to new resources and innovative technologies, the private equity model's method of funding may be fundamentally at odds with patient-first healthcare, and in recent years that inherent tension has gotten ugly, say Eva Gunasekera and Jaclyn Tayabji at Tycko & Zavareei.

  • Opinion

    Now More Than Ever, Lawyers Must Exhibit Professionalism

    Author Photo

    As society becomes increasingly fractured and workplace incivility is on the rise, attorneys must champion professionalism and lead by example, demonstrating how lawyers can respectfully disagree without being disagreeable, says Edward Casmere at Norton Rose.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!